Simplex Trading
CRBP icon

Simplex Trading’s Corbus Pharmaceuticals CRBP Stock Holding History

Simplex Trading’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$150K Buy
+16,000
New +$135K ﹤0.01% 4631
2025
Q2 		– Sell
-1,200
Closed -$6K – 8786
2025
Q1 		$6K Sell
1,200
-200
-14% -$1.77K ﹤0.01% 7419
2024
Q4 		$16K Sell
1,400
-2,900
-67% -$48.6K ﹤0.01% 6842
2024
Q3 		$88K Buy
4,300
+1,600
+59% +$81.9K ﹤0.01% 5358
2024
Q2 		$122K Sell
2,700
-900
-25% -$37.9K ﹤0.01% 5163
2024
Q1 		$141K Buy
+3,600
New +$88.8K ﹤0.01% 5223
2023
Q1 		– Sell
-543
Closed -$1K – 9160
2022
Q4 		$1K Buy
543
+13
+2% +$50 ﹤0.01% 8783
2022
Q3 		$2K Sell
530
-457
-46% -$3.22K ﹤0.01% 9246
2022
Q2 		$7K Sell
987
-13
-1% -$126 ﹤0.01% 8566
2022
Q1 		$15K Sell
1,000
-1,030
-51% -$13.6K ﹤0.01% 8513
2021
Q4 		$37K Sell
2,030
-5,977
-75% -$162K ﹤0.01% 7620
2021
Q3 		$437K Hold
8,007
– – ﹤0.01% 4303
2021
Q2 		$439K Buy
8,007
+7,994
+61,492% +$444K ﹤0.01% 4368
2021
Q1 		$77K Buy
13
+4
+44% +$263 ﹤0.01% 6094
2020
Q4 		$34K Sell
9
-83
-90% -$3.1K ﹤0.01% 6557
2020
Q3 		$494K Buy
92
+22
+31% +$3.98K ﹤0.01% 3013
2020
Q2 		$1.76M Buy
70
+65
+1,300% +$13.1K ﹤0.01% 1616
2020
Q1 		$79K Sell
5
-3
-38% -$507 ﹤0.01% 4612
2019
Q4 		$133K Buy
8
+6
+300% +$887 ﹤0.01% 4202
2019
Q3 		$24K Buy
+2
New +$348 ﹤0.01% 5667
2019
Q2 		– Sell
-3
Closed -$55K – 7191
2019
Q1 		$55K Sell
3
-3
-50% -$662 ﹤0.01% 4927
2018
Q4 		$104K Buy
6
+4
+200% +$798 ﹤0.01% 3824
2018
Q3 		$34K Buy
+2
New +$323 ﹤0.01% 5522
2018
Q2 		– Hold
0
– – – 7130
2018
Q1 		– Sell
-2
Closed -$449 – 5573
2017
Q4 		$2K Sell
2
-2
-50% -$428 ﹤0.01% 5145
2017
Q3 		$4K Sell
4
-1
-20% -$196 ﹤0.01% 4537
2017
Q2 		$10K Sell
5
-1
-17% -$196 ﹤0.01% 3958
2017
Q1 		$13K Sell
6
-11
-65% -$2.7K ﹤0.01% 3701
2016
Q4 		$47K Buy
+17
New +$3.9K ﹤0.01% 2210

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Simplex Trading's CRBP Position: Q1 2026 in Review

Simplex Trading opened a new position in Corbus Pharmaceuticals (CRBP) in Q1 2026: 52,836 shares worth $496K. The stake represents ﹤0.01% of the portfolio and ranks #3272 among its holdings. This is a return to the name: Simplex Trading previously reported a position in CRBP as recently as Q3 2025.

Simplex Trading first reported a position in CRBP in Q3 2016 and has held it in 23 quarters since. The position peaked at $794K in Q2 2020. 107 funds tracked by Wall St. Rank hold CRBP as of Q1 2026.

  • Simplex Trading held 52,836 shares of Corbus Pharmaceuticals worth $496K as of Q1 2026.
  • Corbus Pharmaceuticals was a new Simplex Trading position in Q1 2026.
  • Corbus Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #3272 holding.
  • Simplex Trading first reported a position in Corbus Pharmaceuticals in Q3 2016 and has held it in 23 quarters since.
  • Simplex Trading's Corbus Pharmaceuticals position peaked at $794K in Q2 2020.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.